Talal El Zarif

20PUBLICATIONS
207CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 12, 2025
Myocarditis-Associated Cardiogenic Shock: A Nationwide Multicenter Study.

Talal El Zarif, Alexander P Ambrosini, Andi Shahu

|Sep 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.

Alessio Cortellini, Valentina Santo, Leonardo Brunetti

|Mar 03, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.

Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif

|Feb 04, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.

Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio

|Jan 09, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Tejas Jammihal, Renee Maria Saliby, Chris Labaki

|Jan 08, 2025
How to Use Imaging: Complex Cases of Atherosclerosis, Myocardial Inflammation, and Cardiomyopathy in Cardio-Oncology.

Mohamad Khattab, Mariam Baig, Talal El Zarif

Pageof 4

Frequent Collaborators

9 joint publications

Toni K Choueiri

4 joint publications

Guru Sonpavde

4 joint publications

Alessio Cortellini

4 joint publications

David J Pinato